[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Aims and Scope
Content Coverage
Conflict of Interest
Publication Ethics
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Current Issue
All Issues
Indexing Databases::
Contact Us::
Contact Us
Contact Form
Site Facilities::
Search contents
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 18, Issue 4 (12-2016) ::
J Gorgan Univ Med Sci 2016, 18(4): 100-104 Back to browse issues page
Prevalence of Extended-Spectrum Beta Lactamase enzymes in clinical isolates of Enterobacteriaceae family
SM Moosavian1 , A Rezvanirad * 2
1- Associate Professor, Department of Microbiology, Faculty of Medicine, Ahwaz Jondishapur University of Medical Sciences, Ahwaz, Iran
2- M.Sc Student of Microbiology, Department of Microbiology, Ahwaz Jondishapur University of Medical Sciences, Ahwaz, Iran , a1027rezvani@yahoo.com
Abstract:   (9181 Views)

Background and Objective: Extended-Spectrum Beta Lactamase enzymes (ESBLs) are the most important factor for antimicrobial resistance in Enterobacteriaceae The resistance to beta-lactam antibiotics is the main problem in the bacterial infections therapy. This study was done to determine the prevalence of Extended-Spectrum Beta Lactamase enzymes in clinical isolates of Enterobacteriaceae family.

Methods: In this descriptive study, 240 isolates of Enterobacteriaceae family were collected from clinical specimens obtained in Shohada, Rahimi and Madani hospitals in Khorramabad city, Iran. Antibiotic susceptibility of isolates was performed by disk diffusion method. ESBLs production in all isolates was determined using the combination disk method.

Results: Bacteria strains isolated in this study were Escherichia coli (76%), Klebsiella pneumonia (16.2%), Citrobacter (5.4%), Enterobacter spp. (0.83%) and Proteus (1.6%). The results of antimicrobial susceptibility of isolates showed that the highest rate of antibiotic resistance was toward Ampicillin (88%) and Cefotaxime (43%) and the lowest rate was observed to Amikacin (2.5%). According to the results of the phenotypic tests, 141(59%) isolates out of 240 Enterobacteriaceae were beta-lactamase producers.

Conclusion: ESBL producer isolates and antibiotic resistant due to of Enterobacteriaceae isolated from clinical samples from hospitals are high prevalence in Khorramabad city, Iran.
Keywords: Enterobacteriaceae, Extended-Spectrum Beta Lactamase, Escherichia coli, Klebsiella pneumonia
Full-Text [PDF 184 kb] [English Abstract]   (15729 Downloads) |   |   Abstract (HTML)  (1239 Views)  
Type of Study: Short Communication | Subject: Microbiology
References
1. Shokri D, Mobasherizadeh S, Norouzi M, Yaran M. [Isolation and identification of Carbapenemase KPC producing strains of enterobacteriaceae and determination of their antibiotic susceptibility patterns]. J Isfahan Med Sch. 2013; 31(248): 1247-56. [Article in Persian]
2. Soge OO, Queenan AM, Ojo KK, Adeniyi BA, Roberts MC. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae. J Antimicrob Chemother. 2006 Jan; 57(1): 24-30.
3. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008 Mar; 8(3): 159-66. doi: 10.1016/S1473-3099(08)70041-0
4. Zhao WH, Hu ZQ. Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria. Crit Rev Microbiol. 2013 Feb; 39(1): 79-101. doi:10.3109/1040841X.2012.691460
5. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995 Jun;39(6):1211-33.
6. Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015 Jan; 22(1): 90-101. doi:10.1016/j.sjbs.2014.08.002
7. Luvsansharav UO, Hirai I, Nakata A, Imura K, Yamauchi K, Niki M, et al. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother. 2012 Jul; 67(7): 1769-74. doi:10.1093/jac/dks118
8. Ramazanzadeh R. Etiologic agents and extended-spectrum beta-lactamase production in urinary tract infections in Sanandaj, Iran. Eastern J Med. 2010; 15(2): 57-62.
9. Kasap M, Fashae K, Torol S, Kolayli F, Budak F, Vahaboglu H. Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria. Ann Clin Microbiol Antimicrob. 2010 Jan; 9:1. doi:10.1186/1476-0711-9-1
10. Tollentino FM, Polotto M, Nogueira ML, Lincopan N, Neves P, Mamizuka EM, et al. High prevalence of bla(CTX-M) extended spectrum beta-lactamase genes in Klebsiella pneumoniae isolates from a tertiary care hospital: first report of bla(SHV-12), bla(SHV-31), bla(SHV-38), and bla(CTX-M-15) in Brazil. Microb Drug Resist. 2011 Mar; 17(1): 7-16. doi:10.1089/mdr.2010.0055
11. Clinical and Laboratory Standards Institute. M100-S23, Performance standards for antimicrobial susceptibility testing: 23rd informational supplement. Wayne, PA: CLSI. 2014.
12. Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 2004 Dec; 24(6): 585-91.
13. Mousavian SM, Ahmadkhosravi N, Shoja S. [Survey of frequency in extended-spectrum beta-lactamase producing enterobacteriaceae and determination of the antibiotic resistant pattern in clinical specimens in teaching hospitals of Ahvaz Jundishapur University of Medical Sciences]. Jundishapur Sci Med J. 2014; 13(2): 191-99. [Article in Persian]
14. Ghafourian S, Sekawi Z, Neela V, Khosravi A, Rahbar M, Sadeghifard N. Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection. Sao Paulo Med J. 2012; 130(1): 37-43.
15. Feizabadi MM, Mahamadi-Yeganeh S, Mirsalehian A, Mirafshar SM, Mahboobi M, Nili F, Yadegarinia D. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J Infect Dev Ctries. 2010 Oct; 4(10): 609-15.
16. Gholipour A, Soleimani N, Shokri D, Mobasherizadeh S, Kardi M, Baradaran A. Phenotypic and molecular characterization of extended-Spectrum β-Lactamase produced by Escherichia coli, and Klebsiella pneumoniae isolates in an Educational Hospital. Jundishapur J Microbiol. 2014 Oct; 7(10): e11758. doi:10.5812/jjm.11758
17. Hoseinzadegan H, Hassani A, Azadpoor M, Soleimannezhad S, Mohamadi F. [Screening of extended Spectrum Beta lactamase producing gram negative Bacilli isolated from Clinical Cases]. Medical Laboratory Journal. 2008; 1(2): 20-5. [Article in Persian]
Send email to the article author

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Moosavian S, Rezvanirad A. Prevalence of Extended-Spectrum Beta Lactamase enzymes in clinical isolates of Enterobacteriaceae family. J Gorgan Univ Med Sci 2016; 18 (4) :100-104
URL: http://goums.ac.ir/journal/article-1-2963-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 4 (12-2016) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)